Chronic Inflammation in Obesity and the Metabolic Syndrome

被引:835
作者
Monteiro, Rosario [1 ]
Azevedo, Isabel [1 ]
机构
[1] Univ Porto, Fac Med, Dept Biochem FCT U38, P-4200319 Oporto, Portugal
关键词
C-REACTIVE PROTEIN; TUMOR-NECROSIS-FACTOR; COMMITTED SUBCUTANEOUS PREADIPOCYTES; ADIPOSE-TISSUE; INSULIN-RESISTANCE; WEIGHT-LOSS; SUBCLINICAL INFLAMMATION; FAT DISTRIBUTION; GUT MICROBIOTA; ADIPOCYTE SIZE;
D O I
10.1155/2010/289645
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The increasing incidence of obesity and the metabolic syndrome is disturbing. The activation of inflammatory pathways, used normally as host defence response, reminds us of the seriousness of this condition. There is most probably more than one cause for the activation of inflammation, a timeline of events related to the deterioration of metabolic homeostasis presenting along variable routes. Apparently, metabolic overload evokes several stress reactions, such as oxidative, inflammatory, organelle, and cell hypertrophy stresses, generating vicious cycles that amplify each other leading to dysfunction. Adipocyte hypertrophy, through purely physical reasons, facilitates cell rupture, what will evoke an inflammatory reaction. Inability of adipose tissue development to engulf all incoming fat leads to fat deposition in other organs, mainly in the liver, with marked consequences on insulin resistance. The oxidative stress which accompanies feeding, particularly when there is an excessive ingestion of fat and/or other macronutrients without concomitant ingestion of antioxidant-rich foods/beverages, may contribute to the inflammatory markers attributed to obesity. Moreover, recent data on the microbiota and its interaction with food and with obesity brought new hypothetic mechanisms for the obesity/fat diet relationship with inflammation. Beyond these common confounders, other phenomena, for instance, psychological and/or circadian rhythm disturbances, may likewise contribute to the raise of oxidative/inflammatory status. The difficulty in the management of the obesity/metabolic syndrome pathologies is linked to their multifactorial nature where environmental, genetic, and psychosocial factors interact through highly complex networks.
引用
收藏
页数:10
相关论文
共 117 条
[21]   Association between C-Reactive Protein and Adiposity in Women [J].
Bochud, Murielle ;
Marquant, Fabienne ;
Marques-Vidal, Pedro-Manuel ;
Vollenweider, Peter ;
Beckmann, Jacques S. ;
Mooser, Vincent ;
Paccaud, Fred ;
Rousson, Valentin .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (10) :3969-3977
[22]   The gut microbiota ecology: a new opportunity for the treatment of metabolic diseases? [J].
Burcelin, Remy ;
Luche, Elodie ;
Serino, Matteo ;
Amar, Jacques .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2009, 14 :5107-5117
[23]   Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability [J].
Cani, P. D. ;
Possemiers, S. ;
Van de Wiele, T. ;
Guiot, Y. ;
Everard, A. ;
Rottier, O. ;
Geurts, L. ;
Naslain, D. ;
Neyrinck, A. ;
Lambert, D. M. ;
Muccioli, G. G. ;
Delzenne, N. M. .
GUT, 2009, 58 (08) :1091-1103
[24]   Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota [J].
Cani, Patrice D. ;
Delzenne, Nathalie M. .
CURRENT OPINION IN PHARMACOLOGY, 2009, 9 (06) :737-743
[25]   The Role of the Gut Microbiota in Energy Metabolism and Metabolic Disease [J].
Cani, Patrice D. ;
Delzenne, Nathalie M. .
CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (13) :1546-1558
[26]   Risk factors for the metabolic syndrome - The Coronary Artery Risk Development in Young Adults (CARDIA) study, 1985-2001 [J].
Carnethon, MR ;
Loria, CM ;
Hill, JO ;
Sidney, S ;
Savage, PJ ;
Liu, K .
DIABETES CARE, 2004, 27 (11) :2707-2715
[27]   Prevention conference VII - Obesity, a worldwide epidemic related to heart disease and stroke - Group III: Worldwide comorbidities of obesity [J].
Caterson, ID ;
Hubbard, V ;
Bray, GA ;
Grunstein, R ;
Hansen, BC ;
Hong, YL ;
Labarthe, D ;
Seidell, JC ;
Smith, SC .
CIRCULATION, 2004, 110 (18) :E476-E483
[28]   Serum C-Reactive Protein and White Blood Cell Count in Morbidly Obese Surgical Patients [J].
Chen, Sheng-Bin ;
Lee, Yi-Chih ;
Ser, Kong-Han ;
Chen, Jung-Chien ;
Chen, Shu Chung ;
Hsieh, Hsing-Fang ;
Lee, Wei-Jei .
OBESITY SURGERY, 2009, 19 (04) :461-466
[29]   Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans [J].
Cinti, S ;
Mitchell, G ;
Barbatelli, G ;
Murano, I ;
Ceresi, E ;
Faloia, E ;
Wang, SP ;
Fortier, M ;
Greenberg, AS ;
Obin, MS .
JOURNAL OF LIPID RESEARCH, 2005, 46 (11) :2347-2355
[30]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497